Search Results
204 results
Your search is now limited to «Rheumatoid Arthritis» expert search.
News-Medical.net 02/21/2019 23:20
Behavior change of prolonged smoking cessation may delay or prevent onset of seropositive rheumatoid arthritis.
More from News-Medical.net:
Therefore, a review of the evidence is needed to support the administration of rituximab as regularly scheduled therapy to maintain remission or low disease activity in patients with moderate to severe rheumatoid arthritis.
More from U.S. Department of Health & Human Services - HHS.gov (HHS):
MedPageToday.com 02/21/2019 11:00
Individuals who quit smoking and maintained their nonsmoking status over a long duration of time had a decreased risk of developing seropositive rheumatoid arthritis (RA), an analysis of two large prospective cohorts found.
More from MedPageToday.com:
Healio News 02/20/2019 08:30
Little is known about RA patients’ knowledge about the association between RA and CVD, or how their perceived and actual CVD risk may differ,” they added.
More from Healio News:
FeedNavigator 02/19/2019 19:29
Introduction Patients with rheumatoid arthritis (RA) have 2-5 times increased the risk of premature cardiovascular disease (CVD), which shortens their life expectancy by 5-10 years [1.
More from FeedNavigator:
Arthritis Research & Therapy 02/19/2019 19:00
... by Madison and colleagues that depression, anxiety, and medically unexplained somatic complaints that result in chronic pain “are not inherently comorbid” seems to inappropriately minimize the importance that these conditions have on the lives of RA patients.
More from Arthritis Research & Therapy:
The NDA is supported by data from the global upadacitinib SELECT Phase 3 rheumatoid arthritis program evaluating more than 4,000 patients with moderate to severe rheumatoid arthritis across five of six Phase 3 studies.3-7 In all SELECT Phase 3 studies, upadacitinib met all primary and ranked secondary ...
WN.com 02/19/2019 10:07
NORTH CHICAGO, Ill., Feb. 19, 2019/PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review its New Drug Application (NDA) for upadacitinib for the treatment of adult patients with moderate to severe rheumatoid arthritis.
More from WN.com:
CreakyJoints 02/19/2019 07:20
People with rheumatoid arthritis (RA) who are seropositive — which means they have a positive blood test for autoantibodies such as rheumatoid factor autoantibodies or anti-CCP — may have more severe symptoms and joint deformities compared to RA patients who ...
More from CreakyJoints:
In conclusion, the MCC patients with RA can tolerate radiation therapy.
More from International Journal of COPD:
ClinicalTrials.gov 02/18/2019 10:24
Conditions : Rheumatoid Arthritis; Inflammatory Arthritis Intervention : Sponsors : Arthritis Northwest PLLC; Bristol-Myers Squibb; Discus Analytics LLC Not yet recruiting.
More from ClinicalTrials.gov:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications